The bone regenerative effects of fucosterol in in vitro and in vivo models of postmenopausal osteoporosis

Molecular Nutrition and Food Research

Volumn 58, Issue 6, 2014, Pages 1249-1257

  Lee, Don Gil ^a   Park, Sang Yong ^a   Chung, Won Seok ^a   Park, Jae Hee ^a   Shin, Heon Sub ^a   Hwang, Eunson ^a   Kim, In Ho ^b   Yi, Tae Hoo ^a  

^a Kyung Hee University   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

Brown sea weed; Fucosterol; Osteoblastogenesis; Osteoporosis; Ovariectomized rat

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; FUCOSTEROL; OSTEOCALCIN; PEPTIDE; STIGMASTEROL;

ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; BONE DENSITY; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; FEMALE; FEMUR; HUMAN; METABOLISM; ORAL DRUG ADMINISTRATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; RAT; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; ANIMALS; BONE DENSITY; BONE REGENERATION; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; FEMALE; FEMUR; HUMANS; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEOGENESIS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; STIGMASTEROL;

EID: 84901932188     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300319     Document Type: Article

References (34)

1. Rauner, M., Sipos, W., Pietschmann, P., Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation. Age 2008, 30, 273-282.
2. Harada, S., Rodan, G. A., Control of osteoblast function and regulation of bone mass. Nature 2003, 423, 349-355.
3. Koeneman, K. S., Yeung, F., Chung, L. W., Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 1999, 39, 246-261.
4. Watts, N. B., Bilezikian, J. P., Camacho, P. M., Greenspan, S. L. et al., American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr. Pract. 2010, 16(Suppl 3), 1-37.
5. Lasco, A., Morabito, N., Gaudio, A., Buemi, M. et al., Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major. Osteoporos. Int. 2001, 12, 570-575.
6. Rossouw, J. E., Hormones, genetic factors and gender differences in cardiovascular disease. Cardiovasc. Res. 2002, 53, 550-557.
7. Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T. et al., Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004, 291, 1701-1712.
8. Al-Azzawi, F., The clinical choice between estrogen and bisphosphonates to prevent bone loss: are women being misled?. Womens Health 2013, 9, 221-224.
9. Dang, Z. C., Lowik, C., Dose-dependent effects of phytoestrogens on bone. Trends Endocrinol. Metab. 2005, 16, 207-213.
10. Liu, W. H., Lee, Y. M., Lam, K. K., Chen, Y. F. et al., The role of receptor-interacting protein 140 in the accumulation of fat in ovariectomised rats. Obes. Surg. 2011, 21, 935-940.
11. Gaulin, E., Bottin, A., Dumas, B., Sterol biosynthesis in oomycete pathogens. Plant Signal. Behav. 2010, 5, 258-260.
12. Yoo, M. S., Shin, J. S., Choi, H. E., Cho, Y. W. et al., Fucosterol isolated from Undaria pinnatifida inhibits lipopolysaccharide-induced production of nitric oxide and pro-inflammatory cytokines via the inactivation of nuclear factor-κB and p38 mitogen-activated protein kinase in RAW264.7 macrophages. Food Chem. 2012, 135, 967-975.
13. Khanavi, M., Gheidarloo, R., Sadati, N., Ardekani, M. R. et al., Cytotoxicity of fucosterol containing fraction of marine algae against breast and colon carcinoma cell line. Pharmacogn. Mag. 2012, 8, 60-64.
14. Kim, M. S., Oh, G. H., Kim, M. J., Hwang, J. K., Fucosterol inhibits matrix metalloproteinase expression and promotes type-1 procollagen production in UVB-induced HaCaT cells. Photochem. Photobiol. 2013, 89, 911-918.
15. Boyle, W. J., Simonet, W. S., Lacey, D. L., Osteoclast differentiation and activation. Nature 2003, 423, 337-342.
16. Wei, S., Teitelbaum, S. L., Wang, M. W., Ross, F. P., Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors. Endocrinology 2001, 142, 1290-1295.
17. Bae, Y. J., Kim, J. Y., Choi, M. K., Chung, Y. S., Kim, M. H., Short-term administration of water-soluble silicon improves mineral density of the femur and tibia in ovariectomized rats. Biol. Trace Elem. Res. 2008, 124, 157-163.
18. Guo, H. Y., Jiang, L., Ibrahim, S. A., Zhang, L. et al., Orally administered lactoferrin preserves bone mass and microarchitecture in ovariectomized rats. J. Nutr. 2009, 139, 958-964.
19. Jeon, B. J., Ahn, J., Kwak, H. S., Effect of isoflavone-enriched milk on bone mass in ovariectomized rats. J. Med. Food 2009, 12, 1260-1267.
20. Watkins, B. A., Reinwald, S., Li, Y., Seifert, M. F., Protective actions of soy isoflavones and n-3 PUFAs on bone mass in ovariectomized rats. J. Nutr. Biochem. 2005, 16, 479-488.
21. Gittens, S. A., Wohl, G. R., Zernicke, R. F., Matyas, J. R. et al., Systemic bone formation with weekly PTH administration in ovariectomized rats. J. Pharm. Pharm. Sci. 2004, 7, 27-37.
22. Garnero, P., Ferreras, M., Karsdal, M.A., Nicamhlaoibh, R. et al., The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation. J. Bone Miner. Res. 2003, 18, 859-867.
23. Kawakita, S., Marotta, F., Naito, Y., Gumaste, U. et al., Effect of an isoflavones-containing red clover preparation and alkaline supplementation on bone metabolism in ovariectomized rats. Clin. Interv. Aging 2009, 4, 91-100.
24. Magnusson, P., Larsson, L., Magnusson, M., Davie, M.W. et al., Isoforms of bone alkaline phosphatase: characterization and origin in human trabecular and cortical bone. J. Bone Miner. Res. 1999, 14, 1926-1933.
25. Fernley, H. N., Walker, P. G., Inhibition of alkaline phosphatase by l-phenylalanine. Biochem. J. 1970, 116, 543-544.
26. Seo, H. J., Cho, Y. E., Kim, T., Shin, H. I., Kwun, I. S., Zinc may increase bone formation through stimulating cell proliferation, alkaline phosphatase activity and collagen synthesis in osteoblastic MC3T3-E1 cells. Nutr. Res. Pract. 2010, 4, 356-361.
27. Khosla, S., Minireview: the OPG/RANKL/RANK system. Endocrinology 2001, 142, 5050-5055.
28. Ulrich, D., van Rietbergen, B., Laib, A., Rüegsegger, P, The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 1999, 25, 55-60.
29. Shuid, A. N., Ping, L. L., Muhammad, N., Mohamed, N. et al., The effects of Labisia pumila var. alata on bone markers and bone calcium in a rat model of post-menopausal osteoporosis. J. Ethnopharmacol. 2011, 133, 538-542.
30. Chambers, T. J., Regulation of the differentiation and function of osteoclasts. J. Pathol. 2000, 192, 4-13.
31. Chen, F. P., Wang, K. C., Huang, J. D., Effect of estrogen on the activity and growth of human osteoclasts in vitro. Taiwan J. Obstet. Gynecol. 2009, 48, 350-355.
32. Crusode de Souza, M., Sasso-Cerri, E., Cerri, P. S., Immunohistochemical detection of estrogen receptor beta in alveolar bone cells of estradiol-treated female rats: possible direct action of estrogen on osteoclast life span. J. Anat. 2009, 215, 673-681.
33. Clowes, J. A., Eghbali-Fatourechi, G. Z., McCready, L., Oursler, M. J. et al., Estrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo. Osteoporos. Int. 2009, 20, 761-769.
34. Almeida, M., Martin-Millan, M., Ambrogini, E., Bradsher, R., 3rd et al., Estrogens attenuate oxidative stress and the differentiation and apoptosis of osteoblasts by DNA-binding-independent actions of the ERalpha. J. Bone Miner. Res. 2010, 25, 769-781.